Today: 16 May 2026
Browse Category

NASDAQ:NNRG 16 May 2026

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
16 May 2026
··

Stock Market Today

  • Boeing Shares Fall 3.7% Amid Mixed Analyst Ratings and Insider Selling
    May 15, 2026, 7:22 PM EDT. The Boeing Company (NYSE:BA) shares dropped 3.7% to $220.63 on Friday, with trading volume rising 26% above the daily average. Despite recent analyst upgrades-including ratings of 'buy' and target prices up to $295-Boeing's stock price fell below its 50- and 200-day moving averages. The aerospace giant reported better-than-expected quarterly earnings of -$0.20 per share versus estimates of -$0.68, with revenue up 14% year-over-year to $22.22 billion. Insider selling was noted as EVP Uma M. Amuluru sold 1,503 shares valued at $351,371. Boeing holds a market capitalization of $173.92 billion and a consensus analyst rating of 'Moderate Buy,' reflecting cautious optimism amid volatility.

Latest articles

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

16 May 2026
Bank of America agreed to pay $2.25 million to settle claims it charged duplicate balance-inquiry fees at FCTI-owned ATMs in 7-Eleven stores. Former account holders must file claims by June 29; current customers will receive automatic credits if the court approves the deal. Final approval is set for Aug. 21 in San Diego federal court. The class period covers May 2018 to November 2021.
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

16 May 2026
SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
Go toTop